Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA approves Biosense's ablation catheter:

This article was originally published in Clinica

Executive Summary

The FDA has approved Biosense Webster's Navi-Star temperature ablation catheter for sale in the US. The device is designed for use with the company's Carto electrophysiological mapping system. Together they provide the only three-dimensional mapping technology on the market that combines real-time catheter location and radiofrequency (RF) temperature ablation in a single procedure, claims Biosense. The catheter integrates reproducible pinpoint location and accurate catheter positioning for safe and precise RF ablation procedures, says Diamond Bar, California-based Biosense, a Johnson & Johnson company.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076658

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel